Aura Biosciences May Offer Securities Up To $500M Aggregate; May Sell Up To $200M Common Stock Under Sales Agreement With Jefferies

Auro Biosciences shares are trading lower after the company announced it may offer securities up to an aggregate of $500 million and may sell up to $200 million shares under a sales agreement with Jefferies.

HC Wainwright & Co. Maintains Buy on Aura Biosciences, Lowers Price Target to $18

HC Wainwright & Co. analyst Andres Y. Maldonado maintains Aura Biosciences (NASDAQ:AURA) with a Buy and lowers the price target from $24 to $18.

Aura Biosciences Q2 EPS $(0.48) Misses $(0.38) Estimate

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.38) by 29.73 percent. This is a 2.13 percent decrease over losses of $(0.47) per share